Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Precision BioSciences
Biotech
Lilly's Prevail walks away from Precision gene editing collab
Nine months after Lilly’s Prevail Therapeutics reduced the biobucks value of a gene editing deal with Precision, the Big Pharma unit has walked away.
James Waldron
Apr 17, 2024 8:48am
Precision deals out CAR-T autoimmune rights to TG for $10M
Jan 9, 2024 10:14am
Precision punts early-phase CAR-T to Imugene for $21M upfront
Aug 16, 2023 4:00am
Precision on the partnership prowl for lead asset after FDA chat
Jul 27, 2023 10:57am
Lilly's Prevail drops deal value for Precision gene therapy pact
Jul 7, 2023 10:30am
Nkarta's cell therapy needs specific preconditioning
Jun 27, 2023 11:02am
